SCHEMBL20127375

SCHEMBL20127375

c1ccc(-c2cc3c4cc(-c5c6ccccc6c(-c6ccc7ccccc7c6)c6ccccc56)ccc4oc3c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.41
ALDH1A1 P00352 7/20 0.41
MAPT P10636 6/20 0.41
HPGD P15428 5/20 0.41
HSD17B10 Q99714 4/20 0.41
TSHR P16473 3/20 0.41
ALOX15 P16050 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
CYP1A1 P04798 5/20 0.39
CYP1B1 Q16678 4/20 0.39
KMT2A Q03164 5/20 0.39
MAPK1 P28482 2/20 0.39
CYP1A2 P05177 6/20 0.38
GPR84 Q9NQS5 1/20 0.38
GLA P06280 2/20 0.37
HTT P42858 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP2C9 P11712 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127372 0.99 KDM4E (0.40) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL20127371 0.95 CYP1A1 (0.41) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL20127388 0.92 PGR (0.40) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL10122496 0.91 ALOX5 (0.42) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL20127376 0.91 ALOX5 (0.42) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL20416730 0.91 CYP1A1 (0.40) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL20127384 0.91 CYP1A1 (0.40) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL20127370 0.90 MAPK9 (0.41) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL20127378 0.90 CYP1A1 (0.42) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL22707963 0.90 ALOX5 (0.46) KDM4EALDH1A1MAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 KDM4E 4144/4885ALDH1A1 476/4885MAPT 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.